Pandorum key facts
as of Oct 2026- Developer of functional human tissues designed for tissue engineering and regenerative medicine.
- Pandorum is valued at approximately $46.5M as of Oct 2026 (last reported valuation).
- It has raised $43.7M; the latest was Later Stage VC ($18.0M) in Feb 2026.
- Notable investors include US National Science Foundation, Endless Frontier Labs, Indian Angel Network, Ashish Kacholia, Binny Bansal — 40 tracked in total.
- Status: Privately Held (backing).
Pandorum's last reported valuation, Mar 2024. Nothing priced has surfaced since.
- ·The complete investor list: 40 names
- ·Watch Pandorum: the Monday email on marks, rounds and moves
Pandorum funding rounds
No funding rounds for Pandorum are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Pandorum
40+Pandorum valuation
Pandorum's last reported valuation was $46.5 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.
Pandorum investors
40 investors are on record for Pandorum, including US National Science Foundation, Endless Frontier Labs, Indian Angel Network and Ashish Kacholia.
About Pandorum
Developer of functional human tissues designed for tissue engineering and regenerative medicine. The company's experimental-stage human liver tissue is created using three-dimensional printing technology and acts as an artificial liver during liver failures or liver transplantation, and takes less time to regenerate for medical research and therapeutic applications, enabling surgeons to perform painless liver surgeries to advance regenerative therapies.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2009
- Employees
- 40
- Website
- pandorum.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.